Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4368-4376

  Karunajeewa, Harin A ^a,b   Salman, Sam ^a   Mueller, Ivo ^c   Baiwog, Francisca ^c   Gomorrai, Servina ^c   Law, Irwin ^a   Page Sharp, Madhu ^a   Rogerson, Stephen ^d   Siba, Peter ^c   Ilett, Kenneth F ^a,e   Davis, Timothy M E ^a,f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b WESTERN HEALTH   (Australia)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

^f FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; N ACETYLSULFADOXINE; SULFADOXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA; MALARIA CONTROL; PAPUA NEW GUINEA; PREGNANT WOMAN; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SINGLE DRUG DOSE; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTIMALARIALS; DRUG COMBINATIONS; FEMALE; HUMANS; PREGNANCY; PYRIMETHAMINE; SULFADOXINE; YOUNG ADULT;

EID: 70349307404     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00335-09     Document Type: Article

References (40)

1. Anderson, B. J., and N. H. Holford. 2008. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 48:303-332.
2. Anderson, G. D. 2005. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin. Pharmacokinet. 44:989-1008.
3. Barnes, K. I., F. Little, P. J. Smith, A. Evans, W. M. Watkins, and N. J. White. 2006. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin. Pharmacol. Ther. 80:582-596.
4. Brabin, B. J., L. R. Brabin, J. Sapau, and M. P. Alpers. 1988. A longitudinal study of splenomegaly in pregnancy in a malaria endemic area in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 82:677-681.
5. Bustos, D. G., J. E. Lazaro, F. Gay, A. Pottier, C. J. Laracas, B. Traore, and B. Diquet. 2002. Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines. Trop. Med. Int. Health 7:584-591.
6. Cattani, J. A., J. L. Tulloch, H. Vrbova, D. Jolley, F. D. Gibson, J. S. Moir, P. F. Heywood, M. P. Alpers, A. Stevenson, and R. Clancy. 1986. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am. J. Trop. Med. Hyg. 35:3-15.
7. Chesnutt, A. N. 2004. Physiology of normal pregnancy. Crit. Care Clin. 20:609-615.
8. Cook, I. F., J. P. Cochrane, and M. D. Edstein. 1986. Race-linked differences in serum concentrations of dapsone, monoacetyldapsone, and pyrimethamine during malaria prophylaxis. Trans. R. Soc. Trop. Med. Hyg. 80:897-901.
9. Corvaisier, S., B. Charpiat, C. Mounier, M. Wallon, G. Leboucher, M. Al Kurdi, J. F. Chaulet, and F. Peyron. 2004. Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis. Antimicrob. Agents Chemother. 48:3794-3800.
10. Cox-Singh, J., H. Y. Lu, T. M. Davis, K. F. Ilett, L. P. Hackett, A. Matusop, and B. Singh. 2003. Application of a multi-faceted approach for the assessment of treatment response in falciparum malaria: a study from Malaysian Borneo. Int. J. Parasitol. 33:1545-1552.
11. Dzinjalamala, F. K., A. Macheso, J. G. Kublin, T. E. Taylor, K. I. Barnes, M. E. Molyneux, C. V. Plowe, and P. J. Smith. 2005. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxinepyrimethamine in Malawian children. Antimicrob. Agents Chemother. 49: 3601-3606.
12. Edstein, M. D. 1987. Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man. Chemotherapy 33:229-233. (Pubitemid 17080645)
13. Gerhardy, C. L., and M. Garrett. 2002. Obstetrics and gynaecology for nurses and midwives, 5th ed. Lutheran School of Nursing, Madang, Papua New Guinea.
14. Green, M. D., A. M. van Eijk, F. O. van Ter Kuile, J. G. Ayisi, M. E. Parise, P. A. Kager, B. L. Nahlen, R. Steketee, and H. Nettey. 2007. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J. Infect. Dis. 196:1403-1408.
15. Hekster, C. A., and T. B. Vree. 1982. Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives. Antibiot. Chemother. 31:22-118.
16. Hodge, L. S., and T. S. Tracy. 2007. Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin. Drug Metab. Toxicol. 3:557-571.
17. Jonsson, E. N., and M. O. Karlsson. 1999. Xpose: an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput. Methods Programs Biomed. 58:51-64.
18. Lee, S. J., R. McGready, C. Fernandez, K. Stepniewska, M. K. Paw, S. J. Viladpai-nguen, K. L. Thwai, L. Villegas, P. Singhasivanon, B. M. Greenwood, N. J. White, and F. Nosten. 2008. Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria. Eur. J. Clin. Pharmacol. 64:987-992.
19. Mansor, S. M., V. Navaratnam, M. Mohamad, S. Hussein, A. Kumar, A. Jamaludin, and W. H. Wernsdorfer. 1989. Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers. Br. J. Clin. Pharmacol. 27:381-386.
20. Meyer, U. A., and U. M. Zanger. 1997. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu. Rev. Pharmacol. Toxicol. 37:269-296.
21. Obua, C., M. Ntale, M. S. Lundblad, M. Mahindi, L. L. Gustafsson, J. W. Ogwal-Okeng, W. W. Anokbonggo, and U. Hellgren. 2006. Pharmacokinetic interactions between chloroquine, sulfadoxine, and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Afr. Health Sci. 6:86-92.
22. Parise, M. E., J. G. Ayisi, B. L. Nahlen, L. J. Schultz, J. M. Roberts, A. Misore, R. Muga, A. J. Oloo, and R. W. Steketee. 1998. Efficacy of sulfadoxinepyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am. J. Trop. Med. Hyg. 59:813-822.
23. Penketh, R. J., S. F. Gibney, G. T. Nurse, and D. A. Hopkinson. 1983. Acetylator phenotypes in Papua New Guinea. J. Med. Genet. 20:37-40.
24. Sarikabhuti, B., N. Keschamrus, S. Noeypatimanond, E. Weidekamm, R. Leimer, W. Wernsdorfer, and E. U. Kolle. 1988. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects. Acta Trop. 45: 217-224. (Pubitemid 18237807)
25. Schwartz, D. E., E. Weidekamm, I. Mimica, P. Heizmann, and R. Portmann. 1987. Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects. Chemotherapy 33:1-8.
26. Shulman, C. E., E. K. Dorman, F. Cutts, K. Kawuondo, J. N. Bulmer, N. Peshu, and K. Marsh. 1999. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353:632-636.
27. Smith, C. C., and J. Ihrig. 1959. Persistent excretion of pyrimethamine following oral administration. Am. J. Trop. Med. Hyg. 8:60-62.
28. Tarning, J., N. Lindegardh, A. Annerberg, T. Singtoroj, N. P. Day, M. Ashton, and N. J. White. 2005. Pitfalls in estimating piperaquine elimination. Antimicrob. Agents Chemother. 49:5127-5128.
29. Tett, S. E., and D. J. Cutler. 1987. Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur. J. Clin. Pharmacol. 31:729-731.
30. Trenque, T., N. Simon, I. Villena, C. Chemla, C. Quereux, B. Leroux, R. Jaussaud, G. Remy, D. Dupouy, H. Millart, J. M. Pinon, and S. Urien. 2004. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. Br. J. Clin. Pharmacol. 57:735-741.
31. van Eijk, A. M., J. G. Ayisi, F. O. ter Kuile, J. A. Otieno, A. O. Misore, J. O. Odondi, D. H. Rosen, P. A. Kager, R. W. Steketee, and B. L. Nahlen. 2004. Effectiveness of intermittent preventive treatment with sulphadoxinepyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop. Med. Int. Health 9:351-360.
32. Wang, N. S., X. B. Guo, Q. D. Liu, L. C. Fu, G. Q. Li, and K. Arnold. 1990. Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet. Chemotherapy 36:177-184.
33. Ward, S. A., E. J. Sevene, I. M. Hastings, F. Nosten, and R. McGready. 2007. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect. Dis. 7:136-144.
34. Weidekamm, E., H. Plozza-Nottebrock, I. Forgo, and U. C. Dubach. 1982. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bull. W. H. O. 60:115-122.
35. Weidekamm, E., D. E. Schwartz, U. C. Dubach, and B. Weber. 1987. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. Chemotherapy 33:259-265. (Pubitemid 17080651)
36. Whelpton, R., G. Watkins, and S. H. Curry. 1981. Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status. Clin. Chem. 27:1911-1914.
37. White, N. J. 2005. Intermittent presumptive treatment of malaria. PLoS Med. 1:e3.
38. Winstanley, P. A., W. M. Watkins, C. R. Newton, C. Nevill, E. Mberu, P. A. Warn, C. M. Waruiru, I. N. Mwangi, D. A. Warrell, and K. Marsh. 1992. The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. Br. J. Clin. Pharmacol. 33:143-148.
39. World Health Organization. 2003. Assessment and monitoring of antimalarial drug for the treatment of acute uncomplicated falciparum malaria. World Health Organization, Geneva, Switzerland.
40. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.